US 11590205
Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
granted A61KA61K38/26A61K47/02
Quick answer
US patent 11590205 (Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents) held by XERIS PHARMACEUTICALS, INC. expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- XERIS PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/26, A61K47/02, A61K47/10, A61K47/20